| MeSH term | MeSH ID | Detail |
|---|---|---|
| Vestibulocochlear Nerve Diseases | D000160 | 1 associated lipids |
| Acromegaly | D000172 | 6 associated lipids |
| Actinobacillus Infections | D000189 | 4 associated lipids |
| Actinomycosis | D000196 | 2 associated lipids |
| Addison Disease | D000224 | 3 associated lipids |
| Adenocarcinoma | D000230 | 166 associated lipids |
| Adrenal Hyperplasia, Congenital | D000312 | 2 associated lipids |
| Albuminuria | D000419 | 18 associated lipids |
| Alzheimer Disease | D000544 | 76 associated lipids |
| Angina, Unstable | D000789 | 14 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Mandelin J et al. | Human osteoblasts produce cathepsin K. | 2006 | Bone | pmid:16337236 |
| You L et al. | Osteocytes as mechanosensors in the inhibition of bone resorption due to mechanical loading. | 2008 | Bone | pmid:17997378 |
| Bi Y et al. | Biglycan deficiency increases osteoclast differentiation and activity due to defective osteoblasts. | 2006 | Bone | pmid:16364709 |
| GarcÃa-Hernández A et al. | High glucose concentrations alter the biomineralization process in human osteoblastic cells. | 2012 | Bone | pmid:22086137 |
| Bougioukli S et al. | Combination therapy with BMP-2 and a systemic RANKL inhibitor enhances bone healing in a mouse critical-sized femoral defect. | 2016 | Bone | pmid:26723577 |
| West SL et al. | The effect of exercise and estrogen on osteoprotegerin in premenopausal women. | 2009 | Bone | pmid:18929691 |
| Bateman TA et al. | Osteoprotegerin mitigates tail suspension-induced osteopenia. | 2000 | Bone | pmid:10773583 |
| Seriwatanachai D et al. | Prolactin directly enhances bone turnover by raising osteoblast-expressed receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio. | 2008 | Bone | pmid:18166509 |
| Vanella L et al. | HO-1 expression increases mesenchymal stem cell-derived osteoblasts but decreases adipocyte lineage. | 2010 | Bone | pmid:19853072 |
| Walker CG et al. | Osteopontin is required for unloading-induced osteoclast recruitment and modulation of RANKL expression during tooth drift-associated bone remodeling, but not for super-eruption. | 2010 | Bone | pmid:20828639 |
| Sato M et al. | New 19-nor-(20S)-1alpha,25-dihydroxyvitamin D3 analogs strongly stimulate osteoclast formation both in vivo and in vitro. | 2007 | Bone | pmid:17070129 |
| Zheng Y et al. | Inhibition of bone resorption, rather than direct cytotoxicity, mediates the anti-tumour actions of ibandronate and osteoprotegerin in a murine model of breast cancer bone metastasis. | 2007 | Bone | pmid:17092788 |
| Peng S et al. | The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin. | 2011 | Bone | pmid:21925296 |
| Khoshniat S et al. | Phosphate-dependent stimulation of MGP and OPN expression in osteoblasts via the ERK1/2 pathway is modulated by calcium. | 2011 | Bone | pmid:21147284 |
| Zheng D et al. | The beneficial effect of Icariin on bone is diminished in osteoprotegerin-deficient mice. | 2012 | Bone | pmid:22551876 |
| Liu J et al. | Comparison of the effects of genistein and zoledronic acid on the bone loss in OPG-deficient mice. | 2008 | Bone | pmid:18337202 |
| Buijs JT et al. | Inhibition of bone resorption and growth of breast cancer in the bone microenvironment. | 2009 | Bone | pmid:19041433 |
| Kido S et al. | Expression of RANK is dependent upon differentiation into the macrophage/osteoclast lineage: induction by 1alpha,25-dihydroxyvitamin D3 and TPA in a human myelomonocytic cell line, HL60. | 2003 | Bone | pmid:12810169 |
| Ho TY et al. | Effects of relaxin and estrogens on bone remodeling markers, receptor activator of NF-kB ligand (RANKL) and osteoprotegerin (OPG), in rat adjuvant-induced arthritis. | 2011 | Bone | pmid:21419242 |
| Kudlacek S et al. | Serum levels of osteoprotegerin increase with age in a healthy adult population. | 2003 | Bone | pmid:12810175 |
| Yasuda H et al. | A novel molecular mechanism modulating osteoclast differentiation and function. | 1999 | Bone | pmid:10423033 |
| Ueland T et al. | Growth hormone substitution increases gene expression of members of the IGF family in cortical bone from women with adult onset growth hormone deficiency--relationship with bone turn-over. | 2003 | Bone | pmid:14555269 |
| Nagata N et al. | Inhibition of RANKL-induced osteoclast formation in mouse bone marrow cells by IL-12: involvement of IFN-gamma possibly induced from non-T cell population. | 2003 | Bone | pmid:14555278 |
| LaCroix AZ et al. | OPG and sRANKL serum levels and incident hip fracture in postmenopausal Caucasian women in the Women's Health Initiative Observational Study. | 2013 | Bone | pmid:23735608 |
| Bord S et al. | The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts. | 2003 | Bone | pmid:12633785 |
| Reginster JY et al. | Strontium ranelate treatment increases osteoprotegerin serum levels in postmenopausal osteoporotic women. | 2012 | Bone | pmid:22270053 |
| Kacena MA et al. | Megakaryocyte-mediated inhibition of osteoclast development. | 2006 | Bone | pmid:16782418 |
| Wuyts W et al. | Evaluation of the role of RANK and OPG genes in Paget's disease of bone. | 2001 | Bone | pmid:11165949 |
| Ren W et al. | Effect of oral erythromycin therapy in patients with aseptic loosening of joint prostheses. | 2009 | Bone | pmid:19154802 |
| Naot D et al. | Molecular mechanisms involved in the mitogenic effect of lactoferrin in osteoblasts. | 2011 | Bone | pmid:21515435 |
| Matsuzaki E et al. | Sphingosine-1-phosphate promotes the nuclear translocation of β-catenin and thereby induces osteoprotegerin gene expression in osteoblast-like cell lines. | 2013 | Bone | pmid:23612487 |
| Liang QQ et al. | The expression of osteoprotegerin is required for maintaining the intervertebral disc endplate of aged mice. | 2011 | Bone | pmid:21466864 |
| Mossetti G et al. | Interleukin-6 and osteoprotegerin systems in Paget's disease of bone: relationship to risedronate treatment. | 2005 | Bone | pmid:15777635 |
| Janssens K et al. | An intermediate form of juvenile Paget's disease caused by a truncating TNFRSF11B mutation. | 2005 | Bone | pmid:15777670 |
| Fukushima H et al. | IL-1-induced receptor activator of NF-kappa B ligand in human periodontal ligament cells involves ERK-dependent PGE2 production. | 2005 | Bone | pmid:15780952 |
| Regmi A et al. | Suramin interacts with RANK and inhibits RANKL-induced osteoclast differentiation. | 2005 | Bone | pmid:15780954 |
| Irie A et al. | Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity. | 2007 | Bone | pmid:17560185 |
| Dimitri P et al. | Adipokines, bone-derived factors and bone turnover in obese children; evidence for altered fat-bone signalling resulting in reduced bone mass. | 2011 | Bone | pmid:20932948 |
| Shahnazari M et al. | Bone turnover markers in peripheral blood and marrow plasma reflect trabecular bone loss but not endocortical expansion in aging mice. | 2012 | Bone | pmid:22154841 |
| Ulrich-Vinther M et al. | Gene therapy with human osteoprotegerin decreases callus remodeling with limited effects on biomechanical properties. | 2005 | Bone | pmid:16169783 |
| Buckley KA et al. | Adenosine triphosphate stimulates human osteoclast activity via upregulation of osteoblast-expressed receptor activator of nuclear factor-kappa B ligand. | 2002 | Bone | pmid:12477572 |
| Baek KH et al. | Changes in the serum sex steroids, IL-7 and RANKL-OPG system after bone marrow transplantation: influences on bone and mineral metabolism. | 2006 | Bone | pmid:16905375 |
| Mori K et al. | DU145 human prostate cancer cells express functional receptor activator of NFkappaB: new insights in the prostate cancer bone metastasis process. | 2007 | Bone | pmid:17196895 |
| Tanaka M et al. | Alteration of Dickkopf-1 and receptor activator of nuclear factor-κB ligand during PBSC mobilization in healthy donors by G-CSF. | 2012 | Bone Marrow Transplant. | pmid:22120987 |
| Estanislau IM et al. | Pleiotropic effects of statins on the treatment of chronic periodontitis--a systematic review. | 2015 | Br J Clin Pharmacol | pmid:25444240 |
| Mackie PS et al. | Bisphosphonates regulate cell growth and gene expression in the UMR 106-01 clonal rat osteosarcoma cell line. | 2001 | Br. J. Cancer | pmid:11286476 |
| Beuselinck B et al. | RANK/OPG ratio of expression in primary clear-cell renal cell carcinoma is associated with bone metastasis and prognosis in patients treated with anti-VEGFR-TKIs. | 2015 | Br. J. Cancer | pmid:26528707 |
| Lau YS et al. | Malignant melanoma and bone resorption. | 2006 | Br. J. Cancer | pmid:16641914 |
| Lau YS et al. | Cellular and humoral mechanisms of osteoclast formation in Ewing's sarcoma. | 2007 | Br. J. Cancer | pmid:17533390 |
| Pepe J et al. | Lumbar bone mineral density as the major factor determining increased prevalence of vertebral fractures in monoclonal gammopathy of undetermined significance. | 2006 | Br. J. Haematol. | pmid:16848794 |
| Haaber J et al. | Myeloma cell expression of 10 candidate genes for osteolytic bone disease. Only overexpression of DKK1 correlates with clinical bone involvement at diagnosis. | 2008 | Br. J. Haematol. | pmid:18005268 |
| Magal I et al. | Serum levels of osteoprotegerin and osteoprotegerin polymorphisms in Gaucher disease. | 2006 | Br. J. Haematol. | pmid:16512834 |
| Shalhoub V et al. | Characterization of osteoclast precursors in human blood. | 2000 | Br. J. Haematol. | pmid:11122091 |
| Terpos E et al. | New insights into the pathophysiology and management of bone disease in multiple myeloma. | 2003 | Br. J. Haematol. | pmid:14632767 |
| Chollet ME et al. | Evidence of a colocalisation of osteoprotegerin (OPG) with von Willebrand factor (VWF) in platelets and megakaryocytes alpha granules. Studies from normal and grey platelets. | 2010 | Br. J. Haematol. | pmid:19958354 |
| Terpos E et al. | Bortezomib reduces serum dickkopf-1 and receptor activator of nuclear factor-kappaB ligand concentrations and normalises indices of bone remodelling in patients with relapsed multiple myeloma. | 2006 | Br. J. Haematol. | pmid:17107351 |
| Voskaridou E et al. | Pamidronate is an effective treatment for osteoporosis in patients with beta-thalassaemia. | 2003 | Br. J. Haematol. | pmid:14616979 |
| Politou M et al. | Role of receptor activator of nuclear factor-kappa B ligand (RANKL), osteoprotegerin and macrophage protein 1-alpha (MIP-1a) in monoclonal gammopathy of undetermined significance (MGUS). | 2004 | Br. J. Haematol. | pmid:15327520 |
| Depil S et al. | Evaluation and prognostic value of serum osteoprotegerin in multiple myeloma. | 2005 | Br. J. Haematol. | pmid:15916694 |
| Bord S et al. | Synthesis of osteoprotegerin and RANKL by megakaryocytes is modulated by oestrogen. | 2004 | Br. J. Haematol. | pmid:15238146 |
| Roux S et al. | RANK (receptor activator of nuclear factor-kappaB) and RANKL expression in multiple myeloma. | 2002 | Br. J. Haematol. | pmid:11918537 |
| Bock O et al. | Osteosclerosis in advanced chronic idiopathic myelofibrosis is associated with endothelial overexpression of osteoprotegerin. | 2005 | Br. J. Haematol. | pmid:15982347 |
| Chen WF et al. | Total flavonoid fraction of the Herba epimedii extract suppresses urinary calcium excretion and improves bone properties in ovariectomised mice. | 2011 | Br. J. Nutr. | pmid:20815976 |
| Zhao H et al. | Long-term resveratrol treatment prevents ovariectomy-induced osteopenia in rats without hyperplastic effects on the uterus. | 2014 | Br. J. Nutr. | pmid:24073920 |
| Karieb S and Fox SW | Zinc modifies the effect of phyto-oestrogens on osteoblast and osteoclast differentiation in vitro. | 2012 | Br. J. Nutr. | pmid:22289672 |
| Zhang Y et al. | Erythrina variegata extract exerts osteoprotective effects by suppression of the process of bone resorption. | 2010 | Br. J. Nutr. | pmid:20487580 |
| Hooshmand S et al. | The effect of dried plum on serum levels of receptor activator of NF-κB ligand, osteoprotegerin and sclerostin in osteopenic postmenopausal women: a randomised controlled trial. | 2014 | Br. J. Nutr. | pmid:24780728 |
| Chen WF and Wong MS | Genistein modulates the effects of parathyroid hormone in human osteoblastic SaOS-2 cells. | 2006 | Br. J. Nutr. | pmid:16768824 |
| Wong KC et al. | Drynaria fortunei-derived total flavonoid fraction and isolated compounds exert oestrogen-like protective effects in bone. | 2013 | Br. J. Nutr. | pmid:23302510 |
| Mok SK et al. | Icariin protects against bone loss induced by oestrogen deficiency and activates oestrogen receptor-dependent osteoblastic functions in UMR 106 cells. | 2010 | Br. J. Pharmacol. | pmid:20128811 |
| Brennan TC et al. | Osteoblasts play key roles in the mechanisms of action of strontium ranelate. | 2009 | Br. J. Pharmacol. | pmid:19563530 |
| Michael H et al. | Differential effects of selective oestrogen receptor modulators (SERMs) tamoxifen, ospemifene and raloxifene on human osteoclasts in vitro. | 2007 | Br. J. Pharmacol. | pmid:17420779 |
| Liu W et al. | Polymorphisms in three genes are associated with hemorrhagic stroke. | 2015 | Brain Behav | pmid:26664786 |
| Petri AD et al. | Effects of low-level laser therapy on human osteoblastic cells grown on titanium. | 2010 | Braz Dent J | pmid:21271038 |
| Tera Tde M et al. | The RANK/ RANKL/ OPG interaction in the repair of autogenous bone grafts in female rats with estrogen deficiency. | 2014 | Braz Oral Res | pmid:25229791 |
| Zhang L et al. | Effects of IL-10 and glucose on expression of OPG and RANKL in human periodontal ligament fibroblasts. | 2016 | Braz. J. Med. Biol. Res. | pmid:27074164 |
| Taveira AT et al. | Longitudinal evaluation of hepatic osteodystrophy in children and adolescents with chronic cholestatic liver disease. | 2010 | Braz. J. Med. Biol. Res. | pmid:21049245 |
| Nascimento MM et al. | Elevated levels of plasma osteoprotegerin are associated with all-cause mortality risk and atherosclerosis in patients with stages 3 to 5 chronic kidney disease. | 2014 | Braz. J. Med. Biol. Res. | pmid:25296363 |
| Bezerra MC et al. | RANK, RANKL and osteoprotegerin in arthritic bone loss. | 2005 | Braz. J. Med. Biol. Res. | pmid:15785827 |
| Mariúba MV et al. | Effect of triiodothyronine on the maxilla and masseter muscles of the rat stomatognathic system. | 2011 | Braz. J. Med. Biol. Res. | pmid:21584440 |
| Rachner TD et al. | Dickkopf-1 is regulated by the mevalonate pathway in breast cancer. | 2014 | Breast Cancer Res. | pmid:24528599 |
| Canon J et al. | RANKL inhibition combined with tamoxifen treatment increases anti-tumor efficacy and prevents tumor-induced bone destruction in an estrogen receptor-positive breast cancer bone metastasis model. | 2012 | Breast Cancer Res. Treat. | pmid:22926264 |
| Holen I et al. | Osteoprotegerin (OPG) expression by breast cancer cells in vitro and breast tumours in vivo--a role in tumour cell survival? | 2005 | Breast Cancer Res. Treat. | pmid:16155791 |
| Jacot W et al. | Increased prevalence of vitamin D insufficiency in patients with breast cancer after neoadjuvant chemotherapy. | 2012 | Breast Cancer Res. Treat. | pmid:22562178 |
| Neville-Webbe HL et al. | Osteoprotegerin (OPG) produced by bone marrow stromal cells protects breast cancer cells from TRAIL-induced apoptosis. | 2004 | Breast Cancer Res. Treat. | pmid:15567943 |
| Bénard J | [From metastatic osteolysis a painful message: beginning to understand with osteoprotegerin? | 2000 | Bull Cancer | pmid:11184451 |
| Clézardin P | [The role of RANK/RANKL/osteoprotegerin (OPG) triad in cancer-induced bone diseases: physiopathology and clinical implications]. | 2011 | Bull Cancer | pmid:21700551 |
| Sawajiri M et al. | Different effects of carbon ion and gamma-irradiation on expression of receptor activator of NF-kB ligand in MC3T3-E1 osteoblast cells. | 2006 | Bull. Exp. Biol. Med. | pmid:17415477 |
| Callaci JJ et al. | Binge alcohol-induced bone damage is accompanied by differential expression of bone remodeling-related genes in rat vertebral bone. | 2009 | Calcif. Tissue Int. | pmid:19330277 |
| Bae YJ and Kim MH | Calcium and Magnesium Supplementation Improves Serum OPG/RANKL in Calcium-Deficient Ovariectomized Rats. | 2010 | Calcif. Tissue Int. | pmid:20811796 |
| Rendina D et al. | Bone turnover and the osteoprotegerin-RANKL pathway in tumor-induced osteomalacia: a longitudinal study of five cases. | 2009 | Calcif. Tissue Int. | pmid:19763378 |
| Brändström H et al. | Single nucleotide polymorphisms in the human gene for osteoprotegerin are not related to bone mineral density or fracture in elderly women. | 2004 | Calcif. Tissue Int. | pmid:14508625 |
| Valero C et al. | Osteoprotegerin and bone mass in squamous cell head and neck cancer patients. | 2006 | Calcif. Tissue Int. | pmid:16830204 |
| Brabnikova Maresova K et al. | Acute effects of glucocorticoids on serum markers of osteoclasts, osteoblasts, and osteocytes. | 2013 | Calcif. Tissue Int. | pmid:23247536 |
| de Souza Faloni AP et al. | Jaw and long bone marrows have a different osteoclastogenic potential. | 2011 | Calcif. Tissue Int. | pmid:20862464 |
| Dong SS et al. | Association analyses of RANKL/RANK/OPG gene polymorphisms with femoral neck compression strength index variation in Caucasians. | 2009 | Calcif. Tissue Int. | pmid:19458885 |
| Varga F et al. | Triiodothyronine (T3) and 1,25-dihydroxyvitamin D3 (1,25D3) inversely regulate OPG gene expression in dependence of the osteoblastic phenotype. | 2004 | Calcif. Tissue Int. | pmid:15255076 |
| Tabuchi M et al. | Enhancement of crude bone morphogenetic protein-induced new bone formation and normalization of endochondral ossification by bisphosphonate treatment in osteoprotegerin-deficient mice. | 2005 | Calcif. Tissue Int. | pmid:16193235 |
| Ichinose Y et al. | Osteoclastogenesis inhibitory factor/osteoprotegerin reduced bone loss induced by mechanical unloading. | 2004 | Calcif. Tissue Int. | pmid:15549649 |
| Rude RK et al. | Magnesium deficiency: effect on bone and mineral metabolism in the mouse. | 2003 | Calcif. Tissue Int. | pmid:12370796 |